rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1-2
|
pubmed:dateCreated |
2009-9-1
|
pubmed:abstractText |
We have established monoclonal antibodies (MoAbs) that are directed against hepatitis C virus (HCV)-expressing cells. They showed enhanced tumorigenicity after passage in culture for more than 44 days (RzM6-44d cells). To address the mechanism underlying this phenomenon, we characterized the MoAbs, and found that one of the clones recognized a molecule that was down-regulated in the RzM6-44d cells. This molecule was purified and identified as the 70-kDa thyroid autoantigen Ku70. Moreover, expression of the full-length HCV genome or HCV-core protein sequence in WRL68 human embryonic liver cells reduced the level of Ku70 protein, enhanced the ubiquitination of Ku70, and decreased the activity of DNA-activated protein kinase (DNA-PK). Therefore, it appears that the HCV-core protein facilitates the degradation of Ku70 and reduces DNA-PK activity in noncancerous liver cells.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Nuclear,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Activated Protein Kinase,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Ku autoantigen,
http://linkedlifedata.com/resource/pubmed/chemical/Nuclear Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/PRKDC protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Viral Core Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/nucleocapsid protein, Hepatitis C...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1872-7492
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
144
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
266-71
|
pubmed:meshHeading |
pubmed-meshheading:19467273-Antigens, Nuclear,
pubmed-meshheading:19467273-Cell Line,
pubmed-meshheading:19467273-Cells, Cultured,
pubmed-meshheading:19467273-DNA-Activated Protein Kinase,
pubmed-meshheading:19467273-DNA-Binding Proteins,
pubmed-meshheading:19467273-Female,
pubmed-meshheading:19467273-Hepacivirus,
pubmed-meshheading:19467273-Hepatocytes,
pubmed-meshheading:19467273-Humans,
pubmed-meshheading:19467273-Male,
pubmed-meshheading:19467273-Nuclear Proteins,
pubmed-meshheading:19467273-Ubiquitination,
pubmed-meshheading:19467273-Viral Core Proteins
|
pubmed:year |
2009
|
pubmed:articleTitle |
Hepatitis C virus-core protein facilitates the degradation of Ku70 and reduces DNA-PK activity in hepatocytes.
|
pubmed:affiliation |
Department of Biochemistry, School of Pharmaceutical Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|